[ Price : $8.95]
CBER director Vinay Prasads departure at the end of next month raises questions across the biotechnology sector about how the agen...[ Price : $8.95]
Former FDA official Grail Sipes says questions are emerging about the long-term impact of the Commissioners National Priority Vouc...[ Price : $8.95]
Insulet initiates a Class 1 device correction for certain lots of its Omnipod 5 Automated Insulin Delivery System pods after ident...[ Price : $8.95]
FDA approves Novartis Cosentyx (secukinumab) for treating adolescents aged 12 and older with moderate to severe Hidradenitis Suppu...[ Price : $8.95]
FDA expands the approved use of GSKs Arexvy, a respiratory syncytial virus accine that now includes the in adults aged 18 to 49 wh...[ Price : $8.95]
Eli Lilly issues a public warning that its testing found that compounded tirzepatide with vitamin B12 can produce an unknown impur...[ Price : $8.95]
BridgeBio says its investigational therapy BBP-418 showed consistent clinical benefit and a favorable safety profile in an interim...[ Price : $8.95]
FDA approves Johnson & Johnsons Tecnis PureSee Intraocular Lens, a new extended depth-of-focus lens for use in cataract surgery.